JACOBS LEVY EQUITY MANAGEMENT, INC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 61 filers reported holding OVID THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$239,389
+17.1%
62,3410.0%0.00%0.0%
Q2 2023$204,478
+24.3%
62,341
-2.2%
0.00%0.0%
Q1 2023$164,452
-46.8%
63,741
-61.6%
0.00%
-50.0%
Q4 2022$308,837
-65.1%
166,041
-24.6%
0.00%
-71.4%
Q1 2021$886,000
+918.4%
220,357
+482.3%
0.01%
+600.0%
Q4 2020$87,000
-62.8%
37,843
-7.1%
0.00%
-50.0%
Q3 2020$234,000
+22.5%
40,717
-48.5%
0.00%
-33.3%
Q4 2018$191,000
-1.0%
79,094
+131.9%
0.00%0.0%
Q3 2018$193,00034,1100.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,000,000$7,820,0004.09%
BVF INC/IL 6,631,051$25,927,0000.97%
EcoR1 Capital, LLC 6,082,200$23,781,0000.89%
GLOBEFLEX CAPITAL L P 1,009,125$3,946,0000.71%
Ikarian Capital, LLC 1,124,872$4,398,0000.36%
CHI Advisors LLC 218,510$854,0000.20%
Artal Group S.A. 2,500,000$9,775,0000.20%
DCF Advisers, LLC 139,701$546,0000.19%
Tibra Equities Europe Ltd 78,700$308,0000.10%
XTX Topco Ltd 50,569$198,0000.07%
View complete list of OVID THERAPEUTICS INC shareholders